153 related articles for article (PubMed ID: 2185548)
21. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
22. Cancer-induced hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
[TBL] [Abstract][Full Text] [Related]
23. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice.
Weissglas M; Schamhart D; Löwik C; Papapoulos S; Vos P; Kurth KH
J Urol; 1995 Mar; 153(3 Pt 1):854-7. PubMed ID: 7861550
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandins and hypercalcemia of cancer.
Robertson RP
Med Clin North Am; 1981 Jul; 65(4):845-53. PubMed ID: 7278429
[No Abstract] [Full Text] [Related]
26. Studies on the pathogenesis of cancer hypercalcemia.
Laird Myers WP; Bockman R
Trans Am Clin Climatol Assoc; 1977; 88():177-90. PubMed ID: 898535
[TBL] [Abstract][Full Text] [Related]
27. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
Theriault RL
Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia of malignancy: pathophysiology and treatment.
Adami S; Rossini M
Bone; 1992; 13 Suppl 1():S51-5. PubMed ID: 1581120
[TBL] [Abstract][Full Text] [Related]
30. Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy.
McKee RL; Caulfield MP
Pept Res; 1989; 2(2):161-6. PubMed ID: 2520752
[No Abstract] [Full Text] [Related]
31. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
32. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
Okazaki R
Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia of malignancy: a review of advances in pathophysiology.
Kaplan M
Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
[TBL] [Abstract][Full Text] [Related]
34. Overview of cancer-related hypercalcemia: epidemiology and etiology.
Muggia FM
Semin Oncol; 1990 Apr; 17(2 Suppl 5):3-9. PubMed ID: 2185551
[TBL] [Abstract][Full Text] [Related]
35. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Rosol TJ; Brooks CL; Capen CC
Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
[TBL] [Abstract][Full Text] [Related]
36. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
37. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
38. Ectopic production of calciotropic peptides.
Mundy GR
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):473-87. PubMed ID: 1935916
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcemia in breast cancer: an echo of bone mobilization during lactation?
DeMauro S; Wysolmerski J
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):157-67. PubMed ID: 16025222
[TBL] [Abstract][Full Text] [Related]
40. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
